Navigation Links
Haemonetics' Chairman and CEO Adopts 10b5-1 Stock Trading Plan
Date:5/6/2008

BRAINTREE, Mass., May 6 /PRNewswire-FirstCall/ -- Haemonetics Corporation announced today that Brad Nutter, Chairman and CEO, has adopted a pre-arranged stock trading plan under Rule 10b5-1 of the Securities Exchange Act of 1934.

Rule 10b5-1 plans allow executives to adopt a pre-arranged stock trading plan to buy or sell a specified number of shares of the company's stock. Under the plan, Mr. Nutter will exercise only the new-hire stock options granted to him in 2003 when he was hired by Haemonetics as President and CEO. In 2007, Mr. Nutter was promoted to the position of Chairman of the Board of Directors and CEO. Mr. Nutter is entering into the plan for portfolio diversification purposes.

Mr. Nutter remains in compliance with Haemonetics' executive stock ownership plan.

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing innovative blood management solutions for our customers. Together, our devices and consumables, information technology platforms, and consulting services deliver a suite of business solutions to help our customers improve clinical outcomes and reduce the cost of healthcare for blood collectors, hospitals, and patients around the world. Our technologies address important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit our web site at http://www.haemonetics.com.

CONTACT:

Julie Fallon

Tel. (781) 356-9517

Alternate Tel. (617) 320-2401

fallon@haemonetics.com


'/>"/>
SOURCE Haemonetics Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Haemonetics Reports Strong Results for Fourth Quarter and Fiscal Year End 2008 and Issues Guidance for Continued Strong Growth in Fiscal 2009
2. Haemonetics Sets Date for Fourth Quarter and Fiscal Year End 2008 Earnings Release and Conference Call - May 1, 2008
3. Haemonetics(R) Software Solutions to Launch Application for Workflow Optimization in Blood Collection Centers
4. Haemonetics(R) Reports Strong Results for Third Quarter Fiscal 2008 with Continued Double Digit Growth in Sales
5. Haemonetics Sets Date for Q3FY08 Earnings Release and Conference Call - January 31, 2008
6. Haemonetics Appoints Executive Leadership of European Operations
7. Keiko Hattori Joins Haemonetics as President of Haemonetics Japan
8. Haemonetics Webcast Presentation
9. Chrysler LLC Chairman and CEO Bob Nardelli and Chrysler Foundation Recognized by Larry King Cardiac Foundation for Dedication to Improving Lives of Others
10. Statement by H.E. Jakaya Mrisho Kikwete, President of the United Republic of Tanzania, and Chairman of the African Union, in Response to UN-SG Call to Action on Malaria
11. AMN Healthcare Services Elects Douglas D. Wheat as Chairman of the Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... ... 2017 , ... Dr. Angela Cotey, a noted general dentist in Mt. Horeb, ... with or without a referral. Dr. Cotey knows that interceptive orthodontics in ... When patients receive early treatment, they may achieve straight teeth with less treatment in ...
(Date:3/29/2017)... ... March 29, 2017 , ... Curio Wellness , a premium medical ... of the company’s executive management team with prominent executives from both inside and outside ... Chief Operating Officer, Ted Dumbauld , who has more than twenty years of ...
(Date:3/29/2017)... ... , ... Immunotherapy has emerged as one of the most promising options for ... the next revolution in our fight against this complex disease. One of the most ... inhibitors such as PD-1 and PD-L1 inhibitors. , While a few single analyte immunohistochemistry ...
(Date:3/29/2017)... , ... March 29, 2017 , ... The Wharton School ... and Julie Taffet Moelis, W’81, have made a $10 million gift to establish the ... opportunity that will provide a pathway to a Wharton MBA for highly-qualified Penn undergraduates ...
(Date:3/28/2017)... Los Angeles, CA (PRWEB) , ... March 28, 2017 , ... ... “wake-up call” asking the American public to take the Diabetes Risk Test to find ... the event, the Los Angeles World Airports will light up the evening sky by ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... , March 29, 2017 Wound care ... promote healing of the wound. The industry mainly consists ... products for the treatment of wounds caused by mechanical, ... due to diseases such as diabetes, skin related diseases, ... Europe was the largest region in ...
(Date:3/29/2017)... , March 29, 2017  BioSpecifics Technologies Corp. ... continues to develop collagenase based-therapies with a first ... marketed as XIAFLEX ®  in the U.S. and ... present a corporate overview at the upcoming 16 ... April 5, 2017 at 8:00 a.m. ET in ...
(Date:3/29/2017)... and Markets has announced the addition of the "South Korean Proton ... report to their offering. ... The South Korean Proton Therapy Market is expected to almost triple ... Therapy Market for South Korea was valued at ... plays an important role in delivering comprehensive cancer care to children and ...
Breaking Medicine Technology: